Premium
Aoti Inc. (AOTI)
LSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
AOTI, Inc. 17 December 2024 17 December 2024 AOTI, INC. (the "Company" or "Group" or "AOTI") Grant of performance share awards to CFO under Long Term Incentive Plan AOTI, INC., a...
AOTI, Inc. 16 December 2024 16 December 2024 AOTI, INC. (the "Company" or "Group" or "AOTI") Patient Enrolment Commences for VLU Clinical Trial of TWO2 therapy AOTI, INC. (AIM:...
AOTI, Inc. 12 December 2024 12 December 2024 AOTI, INC. (the "Company" or "Group" or "AOTI") AOTI Awarded Five Year Extension To Veterans Administration Contract AOTI, INC., a...
AOTI, Inc. 20 November 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...
AOTI, Inc. 11 November 2024 11 November 2024 AOTI, INC. (the "Company" or "Group" or "AOTI") CMS commences formal review for Topical Oxygen Therapy coverage AOTI, INC. (AIM: AOTI), a...
AOTI Inc on Monday said it was satisfied with its operational progress as revenue grew, however higher costs led to a ...
AOTI, Inc. 16 September 2024 16 September 2024 AOTI, Inc. (the "Company" or "Group" or "AOTI") 2024 Interim Results Robust performance and progress achieved against strategy during H1...
ide, California-based medical technology firm - Provides trading update for the six months ended June 30. Says trading ...
AOTI, Inc. 15 August 2024 15 August 2024 AOTI, INC. (the "Company" or "Group" or "AOTI") Pre-close Trading Update Good operational progress: the Group remains confident of meeting...
AOTI, Inc. 29 July 2024 29 July 2024 AOTI, INC. (the "Company" or "Group" or "AOTI") AOTI announces US FDA 510(k) Clearance of NEXATM NPWT System for use in the home care setting ...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4 | -3.47826086957 | 115 | 116 | 111 | 3112 | 115 | DE |
| 4 | -18 | -13.9534883721 | 129 | 129 | 111 | 5167 | 119.42014561 | DE |
| 12 | -23 | -17.1641791045 | 134 | 135 | 111 | 9143 | 127.3763252 | DE |
| 26 | -23 | -17.1641791045 | 134 | 136 | 111 | 7154 | 130.28911114 | DE |
| 52 | -24.5 | -18.0811808118 | 135.5 | 136 | 111 | 10517 | 132.17328586 | DE |
| 156 | -24.5 | -18.0811808118 | 135.5 | 136 | 111 | 10517 | 132.17328586 | DE |
| 260 | -24.5 | -18.0811808118 | 135.5 | 136 | 111 | 10517 | 132.17328586 | DE |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
